Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
COVID-19 vaccine, Health Canada
Updated Pfizer-BioNTech’s COVID-19 vaccine approved by Health Canada
Health Canada approved Pfizer-BioNTech’s updated COVID-19 vaccine on Tuesday, marking its third authorization of vaccine formulations that protect against the most recently circulating variants of the virus.
HSA approves Pfizer’s new RSV vaccine
This is the first RSV vaccine approved in Singapore for use in older adults and pregnant individuals, providing critical protection to infants and seniors
Health Sciences Authority approves Pfizer’s respiratory syncytial vaccine
Pfizer Singapore announced that the Health Sciences Authority has approved the company’s Abryvso vaccine for respiratory syncytial virus (RSV).
Pfizer's updated COVID-19 vaccine approved, Health Canada says
Pfizer-BioNTech's updated vaccine to protect against a recently circulating variant of COVID-19 is authorized, Health Canada said on Tuesday.
Pfizer’s updated COVID-19 vaccine approved by Health Canada
The mRNA vaccine, called Comirnaty, targets the KP.2 subvariant of Omicron, replacing the previous version which targeted the XBB.1.5 Omicron subvariant.
Health Canada approves Pfizer-BioNTech’s updated COVID-19 vaccine
Pfizer Canada says Health Canada has approved its updated COVID-19 vaccine that protects against one of the most recently circulating variants of the virus. Packaging for the Pfizer's updated COVID vaccine for ages 12 and up is shown in an August 2024 handout photo.
Pfizer Canada and BioNTech Receive Health Canada Approval of Omicron KP.2 Variant Adapted COVID-19 Vaccine
Omicron KP.2 variant adapted vaccine COMIRNATY is now authorized in Canada for individuals 6 months of age and older. It is expected to be available in Canada in the coming weeks. -- The updated COVID-19 vaccine is tailored to the KP.
Novavax, COVID-19 vaccine
What to Know About Novavax, the 'Other' COVID Vaccine
Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.
On the hunt for Novavax: Why people are seeking out the 'traditional' COVID vaccine
Although Pfizer's and Moderna’s COVID-19 vaccines have been stealing the spotlight for years, some people are actively seeking out the lesser-known Novavax for their updated booster this fall. Multiple people have been claiming on social media that Novavax comes with fewer side effects or none at all — “not even a sore arm,
COVID-19 vaccines for kids: What you need to know
Learn about the safety and effectiveness of COVID-19 vaccines for kids, the possible side effects, and the benefits of vaccination.
Reuters on MSN
10m
Pfizer v Moderna COVID vaccine patents battle to go to appeal in UK
The High Court gave a mixed ruling in July, ruling that one of Moderna's two patents relating to the messenger RNA (mRNA) ...
1d
Dr Roland denies instilling fear about Pfizer vaccine
SEPANG: Dr Roland Victor, who is charged with making and initiating the transmission of offensive videos about the Covid-19 ...
5d
S.A. had a COVID-19 summer and the winter surge is next. Can the new vaccine slow it?
A summer wave of cases locally and across the country may be on the decline and a vaccine targeting the latest variants is ...
6d
COVID-19 2024 fall guide: Everything Canadians should know about new Moderna vaccine, current variants and more
NACI added that anyone above 6 months of age who isn't considered high risk "may receive the most recently updated vaccine in ...
1d
Moderna's updated COVID-19 vaccine is coming to Alberta, but Novavax shots are not
"Canada's current contract with Novavax only provides access to domestically manufactured vaccines, which Novavax has been unable to confirm for the 2024-25 season," a Health Canada spokesperson said ...
Yahoo Finance
2d
Vicebio secures $100m to advance RSV and hMPV vaccine combo to Phase I
GSK secured the first US Food and Drug Administration (FDA) approval for an adult RSV
vaccine
in May 2023, called Arexvy.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
COVID
RSV
Health Canada
Novavax
European Union
Feedback